HomeVERV • NASDAQ
add
Verve Therapeutics Inc
Previous close
$6.00
Day range
$6.00 - $6.25
Year range
$5.84 - $21.42
Market cap
515.12M USD
Avg Volume
1.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.14M | 408.30% |
Operating expense | 12.28M | 7.37% |
Net income | -48.35M | -17.69% |
Net profit margin | -939.97 | 76.85% |
Earnings per share | -0.69 | -2.99% |
EBITDA | -52.43M | -12.07% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 623.95M | 12.46% |
Total assets | 752.69M | 10.82% |
Total liabilities | 153.19M | 19.41% |
Total equity | 599.50M | — |
Shares outstanding | 83.62M | — |
Price to book | 0.82 | — |
Return on assets | -19.76% | — |
Return on capital | -22.26% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -48.35M | -17.69% |
Cash from operations | -40.68M | -23.68% |
Cash from investing | -8.89M | 94.72% |
Cash from financing | 177.38M | 347.96% |
Net change in cash | 127.81M | 179.09% |
Free cash flow | -23.74M | -10.35% |
About
Founded
2018
Headquarters
Website
Employees
255